Phenothiazines as a solution for multidrug resistant tuberculosis: From the origin to present

International Microbiology

Volumn 18, Issue 1, 2015, Pages 1-12

  Kristiansen, Jette E ^a   Dastidar, Sujata G ^b   Palchoudhuri, Shaurosen ^b   Roy, Debalina Sinha ^b   Das, Sukhen ^c   Hendricks, Oliver ^a   Christensen, Jørn B ^d  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Department of Microbiology   (India)

^c JADAVPUR UNIVERSITY   (India)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Mycobacterium tuberculosis; Phenotiazines; Thioridazine; Tuberculosis

Indexed keywords

CHLORPROMAZINE; METHDILAZINE; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE; THIORIDAZINE; TRIFLUOPERAZINE; TUBERCULOSTATIC AGENT;

DRUG EFFECTS; HUMAN; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTIPSYCHOTIC AGENTS; ANTITUBERCULAR AGENTS; CHLORPROMAZINE; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PHENOTHIAZINES; THIORIDAZINE; TRIFLUOPERAZINE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84941369055     PISSN: 11396709     EISSN: 16181905     Source Type: Journal    
DOI: 10.2436/20.1501.01.229     Document Type: Review

References (60)

1. Abbate E, Vescovo M, Natiello M, Cufre M, Garcia A, Gonzalez Montaner P, Ambroggi M, Ritacco V, van Soolingen D (2012) Successful alternative treatment of extensively drug resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin, and thioridazine. J Anti-microb Chemother 67:473-477
2. Adams KN, Takaki K, Connolly LE, Weidenhoft H, Winglee K, Humbert O, Edelstein PH, Cosma CL, Ramakrishnan L (2011) Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145:39-53
3. Advani MJ, Siddique I, Sharma P, Reddy H (2012) Activity of trifluoperazine against replicating, non-replicating and drug resistant M. tuberculosis. PLoS ONE 7:1-9
4. Amaral L, Kristiansen JE, Abebe LS, Millett W (1996) Inhibition of the respiration of multidrug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. J Antimicrob Chemother 38:1049-1053
5. Amaral L, Viveiros M, Kristiansen JE (2001) Phenothiazines: potential alternatives for the management of antibiotic resistant infections of tuberculosis and malaria in developing countries. Trop Med Int Health 6:1016-1022
6. Amaral L, Boeree MJ, Gillespie SH, Udwadia ZF, van Soolingen D (2010) Thioridazine cures extensively drug resistant tuberculosis (XDR-TB) and the need for global trial is now! Int J Antimicrob Agents 35:524-526
7. Amaral L, Martins M, Viveiros M (2007) Enhanced killing of intracel-lular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. J Antimicrob Chemother 59:1237-1246
8. Angeby K, Jureen P, Chryssanthou E, Schön T (2012) Tentative susceptibility testing breakpoint for the neuroleptic drug thioridazine, a treatment option for multi- and extensively drug resistant tuberculosis. Int J Mycobacteriol 1:177-179
9. Bodoni P (1899) Dell'azione sedative del blue di metilene in varie forme di psicosi. Clinica Medica Italiana 24:217-222
10. Bourdon JL (1961) Contribution to the study of the antibiotic properties of chlorpromazine or 4560 RP. Ann Inst Pasteur 101:876-386
11. Bovet D, Fournel J, Charpentier P (1947) Pharmacodynamic properties of diethylaminoethylphenothiazine hydrochloride Therapie (Paris) 2:115-119
12. Campbell FL, Sullivan WN, Smith LE, Haller HL (1934) Insecticidal tests of synthetic organic compounds—chiefly tests of sulphur compounds against culicine mosquito larvae. J Econ Entomol 27:1176-1186
13. Chakrabarty AN, Bhattacharya CP, Dastidar SG (1993) Antimycobacte-rial activity of methdilazine(Md), an antimicrobic phenothiazine. APMIS 101:449-454
14. Charpentier P, Guillot P, Jacob R, Gaudecho J, Buisson P (1952) Recherches sur les di-methylamino-propyl-W-phenothiazine. C.R. Acad Sc 235: 59-60
15. Christensen JB, Hendricks O, Chaki S, Mukherjee S, Das A, Pal TK, Dastidar SG Kristiansen JE (2013) A comparative analysis of in vitro and in vivo efficacies of the enantiomers of thioridazine and its racemate. PLoS ONE 8:1-6
16. Crowle JA, Douvas GS, May MH (1992) Chlorpromazine: A drug potentially useful for treating mycobacterial infections. Chemotherapy 38:410-419
17. Dastidar SG, Kristiansen JE, Molnar J, Amaral L (2013) Role of phenothiazines and structurally similar compounds of plant origin in the fight against infections by drug resistant bacteria. Antibiotics 2:58-71
18. Delay J, Deniker P (1952) Réactions biologiques observées au cours du traitement par le chlorhydrate de diméthyl-amino-propyl-V-chlorophé-nothiazine (4560 R.P.). C.R. Congrés Médicine Alién Neurology France 50:514-518
19. DiMasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: new estimates of drug development costs. J Health Econo 22:151-185
20. Dutta NK, Mazumdar K, Dasgupta A, Dastidar SG (2009) Activity of the phenothiazine methdilazine alone or in combination with isoniazid or streptomycin against Mycobacterium tuberculosis in mice. J Medical Microbiol 58:1667-1678
21. Dutta NK, Alsultan A, Peloquin CA, Karakousis PC (2013) Preliminary pharmacokinetic study of repeated doses of rifampin and rifapentine in guinea pigs. Antimicrob Agents Chemother 57: 1535-1537
22. Dutta NK, Pinn ML, KaraKousis PC (2014) Reduce emergence of iso-niazid resistance with concurrent use of thioridazine against acute murine tuberculosis. Antimicrob Agents Chemother 58:4048-4053
23. Ehrlich P (1956) Modifikation der von Koch angegebenen Methode der Färbung von Tuberkelbazillen. Dtsch. Med. Wschr. In: Himmelweit F, Marquardt M, Dale H (eds) The collected papers of Paul Ehrlich, Vol 1. Histology, Biochemistry and Pathology, Pergamon Press, London, pp 311-313
24. Feinberg AP, Snyder SH (1975) Phenothiazine drugs: structure activity relationships explained by a confirmation that mimics dopamine. Proc Nat Acad Sc USA 72:1899-1903
25. Fourneau E, Trefouel J, Trefouel M, Bovet D, Benoit G (1931) Contribution à la chimiothérapie du paludisme essais sur les calfates. Ann Inst Pasteur 46: 514-541
26. Gadre DV, Talwar V (1999) In vitro susceptibility testing of Mycobacterium tuberculosis strains to trifluoperazine. J Chemother 11:203-206
27. Geiger H, Finkelstein BA (1954) Largactil in the treatment of tuberculosis. Schweiz Med Wschr 84:1063-1064
28. Gruenke LD, Craig JC, Klein FD, Nguyen TL, Hitzemann BA, Holaday JW, Loh HH, Braff L, Fischer A, Glick ID, et al. (1985) Determination of chlorpromazine and its major metabolites by GC/MS: application to biological fluids. Biomed Mass Spectrom 12:707-713
29. Guttmann P, Ehrlich P (1891) Über die Wirkung des Methylenblau bei Malaria. Berliner Klinische Wschr 28:953-956
30. Halpern BN, Ducroit R (1946) Recherches expérimentales sur une nouvelle série chimique des corps doués de propriétés antihistaminiques puissantes; les dérivés de la thiodiphénylamine (T.D.A). C.R. Soc Biology 140:361-363
31. Harwood PD (1946) Research on phenothiazine as an anthelmintic. Science Model 62:32-42
32. Hendricks O, Christensen JB, Kristiansen JE (2004) Antibakterielle Eigenschaften der Phenothiazine. Eine Behandlungsoption für die Zukunft? Chemother J 13:203-205
33. Kaatz GW, Moudgal W, Seo SM, Kristiansen JE (2003) Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococ-cus aureus. Antimicrob Agents Ch 47:719-726
34. Koch R (1882) Die Ätiologie der Tuberkulose. Berliner Klinische Wschr 19:221-230
35. Kristiansen JE, Vergmann B (1986) The antibacterial effect of selected phenothiazines and thioxanthenes on slow growing mycobacteria. Acta Path Micro IM B 94:393-398
36. Kristiansen JE, Hendricks O, Delvin T, Butterworth TS, Aagaard L, Christiansen JB, Flores VC, Keyzer H (2007) Reversal of resistance in microorganisms by help of non-antibiotics. J Antimicrob Chemother 59:1271-1279
37. Levaditi C, Chaigneau-Erhard H, Henry-Eveno J (1951) L'antihista-minique 3277 RP (Phenergan) agit-il curativement dans la tuberculosis experimentale de la souris? C.R. Soc Biol 145:1454-1456
38. Machado D, Couto I, Perdigao J, Rodrigues L, Portugal I, Baptista P, Veigas B, Amaral L, Viveiros M (2012) Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis. PloS ONE 7:e34538.
39. Macht DI, Hoffmaster T (1948) Influence of benadryl and pyribehzas-sine on the neuromuscular system of rats. Federal Proceedings 7:242
40. Macht DI, Mora CF (1921) Effect of opium alkaloids on the behaviour of rats in the circular maze. J. Pharmacol Exp Therap 16:219-223
41. Martins M, Viveiros M, Kristiansen JE, Molnar J, Amaral L (2007) The curative activity of thioridazine on mice infected with Mycobacterium tuberculosis. In Vivo 21:771-776
42. Molnar J, Beladi I, Foldes I (1977) Studies on anti-tuberculotic action of some phenothiazine derivatives in vitro. Zentral Bakteriol (Orig A) 239:521-526
43. Mukherjee S, Chaki S, Barman S, Das S, Koley H, Dastidar SG (2012) Effective elimination of drug resistance genes in pathogenic Pseudomonas aeruginosa by antipsychotic agent thioridazine. Current Res Bacte-riol 5:36-41
44. Ordway D, Viveiros M, Leandro C, Bettencourt R, Almeida J, Martins M, Kristiansen JE, Molnar J, Amaral L (2003) Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 47:917-922.
45. Pluta K, Morak-Milodawska B, Jelen M (2011) Recent progess in biological activities of synthesized phenothiazines. Europ J Med Chem 46:3179-3189
46. Popper M, Lorian V (1959) L'action de la chlorpromazine sur les microbes et le complexe bacteriostatique in vitro. Presse Med 67:212-213
47. Ratnakar P, Murthy PS (1993) Trifluoperazine inhibits the incorporation of labelled precursors into lipids, proteins and DNA of Mycobacterium tuberculosis H37Rv. FEMS Microb Lett 110:291-294
48. Rodrigues L, Sampaio D, Couto I, Machado D, Kern WV, Amaral L, Viveiros M (2009) The role of efflux pumps in macrolide resistance in Mycobacterium avium complex. Int J Antimicrob Agents 34:529-533
49. Rodrigues L, Wagner D, Viveiros M, Sampaio D, Couto I, Vavra M, Kern WV, Amaral L (2008) Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis. J Antimicrob Chemother 61:1076-1082
50. Sakula A (1979) Robert Koch: Founder of the science of bacteriology and discoverer of the tubercle bacillus: A study of his life and work. Brit J Dis Chest 73:389-394
51. Sigwald J, Bouthier D (1953) Le chlorhydrate de chloro-3(dimethyl-amino-3-propyl)-10-phenothiazine en practique neuro-psychiatrique courante. Ann Medicine 54:150-182
52. Simons SO, Kristiansen JE, Hajos G, et al. (2013) Activity of the efflux pump inhibitor SILA 421 against drug-resistant tuberculosis. Int J An-timicrob Agents 41:488-489
53. Svendsen CN, Froimowitz M, Hrbek C, Campbell A, Kula N, Baldessarini RJ, Cohen BM, Babb S, Teicher MH, Bird ED (1988) Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thio-ridazine: Evidence for different stereoselectives at D1 and D2 receptors in rat brain. Neuropharmacology 27:1117-1124.
54. van Ingen J, van der Laan T, Amaral L, Dekhuijzen R, Boeree MJ, van Soolingen D (2009) In vitro activity of thioridazine against mycobacteria. Internat J Antimicrob Agents 34:190-191
55. van Soolingen D, Hernandez-Pando R, Orozco H, Aguilar D, Magis-Escurra C, Amaral L, van Ingen J, Boeree MJ (2010) The antipsychotic thioridazine shows promising theraupetic activity in a mouse model of multidrug-resistant tuberculosis. PLoS ONE 5:e12640
56. Viveiros M, Leandro C, Amaral L (2003) Mycobacterial efflux pumps and chemotherapeutic implications. Int J Antimicrob Agents 22:274-278
57. Viveiros M, Dupont M, Rodrigues L, Couto I, Davin-Regli A, Martins M, Pages JM, Amaral L (2007) Antibiotic stress, genetic response and altered permeability of E. coli. PLoS ONE 2:365-372
58. Winter C, Flataker L (1951) The effect of antihistaminic drugs upon the performance oftrained rats. J Pharmacol Exp Ther 101:56-162
59. Wainwright M, Amaral L, Kristiansen JE (2012) The evolution of anti-mycobacterial agents from non-antibiotics. Open J Pharmacol 2:1-11
60. Zeihl F (1882) Zur Färbung des Tuberkelbacillus. Dtsch Med Wshr 8: 451-453